Subscribe


Draft approval for Medicines Australia conduct code

ACCC proposes three year authorisation for pharmaceutical code of conduct.

The Australia Competition and Consumer Commission has just announced its draft approval for edition 17 of Medicine Australia’s Code of Conduct.

“The ACCC considers that the Code results in public benefits by providing greater transparency around the relationships between pharmaceutical companies and healthcare professionals,” said ACCC chairman Rod Sims.

However he added that community expectations of disclosure by the industry have increased, saying the ACCC “considers Medicines Australia could go further in ensuring the code meets these expectations now and in the future”.

The Commission has encouraged MA to look for ways to address concerns that have been raised during the ACCC consultation process, including improving the accessibility of reports and the complaints process, as well as “considering disclosure of payments made to individual healthcare professionals”.

MA sought a five year determination, but the draft approval proposes three years of authorisation and during this period the ACCC suggested the organisation could complete work it has already commenced on reviewing the code and make any resulting changes.

Submissions are now being sought on the draft determination.

More information in Monday’s Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 26 Oct 12

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

21 Sep

Travel Specials 21 Sep 17 - Fly Free with Voyages to Antiquity Grand ...


21 Sep

Dispensary Corner 21 Sep 17 - AN INDIANA food processing plant accidently turned ...


21 Sep

Pfizer sues J&J - ON WEDNESDAY, Pfizer filed a complaint in ...


21 Sep

Singulair queried - MERCK Sharp & Dohme's asthma medication Singulair ...


21 Sep

AIHW recruiting - THE Australian Institute of Health and Welfare ...


21 Sep

Dementia publication fires up neurons - UNIVERSITY of Queensland experts are keeping people ...


21 Sep

Online medicine risks - THE Royal Australian College of General Practitioners ...


21 Sep

Antibiotic paucity - THE World Health Organization has reiterated its ...


21 Sep

Pharmacist-led digital care outcomes - PHARMACIST-LED digital healthcare can improve anti-hypertensive medication ...


21 Sep

Indication extensions - THE Therapeutic Goods Administration has posted broadened ...


21 Sep

S4 to S3 switch plans - WHILE it is understood that the individual ...


21 Sep

Lax-Sachets recall - AFT Pharmaceuticals, in consultation with the TGA, ...


21 Sep

APC Council ‘renewal’ - THE president of the Australian Pharmacy Council ...


21 Sep

TGA labeling rules update - TO REDUCE medication errors, medicine labels need ...


20 Sep

Dermal Therapy Very Dry Skin Lotion - DERMAL Therapy Very Dry Skin Lotion is ...


20 Sep

Sensitive SPF 50+ Sunscreen - TO cater for those with sensitive skin, ...


20 Sep

Clinical Protection Anti-Perspirant Deodorant by Dove - DOVE Clinical Protection Anti-Perspirant Deodorant combines clinical ...


20 Sep

Hello Brows 2-in-1 Stylus by Ulta3 - ULTA3 Hello Brows 2-in-1 Stylus is a ...


20 Sep

Dispensary Corner 20 Sep 17 - TALK about flush with cash - Geneva ...


20 Sep

Medlab 20 year patent - AUSTRALIAN-LISTED medical life science company Medlab Clinical ...



Show Pharmacy Daily items by month: